Updated May 21, 2020

The innovation has no owner

Claim it

The FREND™ COVID-19 IgG/IgM Duo is a point-of-care testing (POCT) which can be used to check whether patients have developed immune responses to SARS-CoV-2 using human serum or plasma.

The FREND™ COVID-19 IgG/IgM Duo is a point-of-care testing (POCT) which can be used to check whether patient has developed immune response to SARS-CoV-2 using human serum or plasma. For COVID-19 IgG/IgM Duo, its detection is based on a fluorescent immunoassay showing qualitative result. Originally, the FREND™ System is a quantitative assay and it can be used to detect additional markers for add...
SEE ALL
The FREND™ COVID-19 IgG/IgM Duo is a point-of-care testing (POCT) which can be used to check whether patient has developed immune response to SARS-CoV-2 using human serum or plasma. For COVID-19 IgG/IgM Duo, its detection is based on a fluorescent immunoassay showing qualitative result. Originally, the FREND™ System is a quantitative assay and it can be used to detect additional markers for additional studies.
SEE LESS
Testing
  
South Korean Government
  

Stage 3: Proof of Concept

Focus Areas:

Prevention & Vaccination

Prevention & VaccinationSEE LESS

Implemented In:

Korea, South

Korea, SouthSEE LESS

1
Country Implemented In

Milestone

Apr 2020
New Country Implemented In
Korea, South